Last Updated : March 8, 2023
Details
FilesProject Status:
Complete
Therapeutic Area:
Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0018-000
Review Type: Panel
Provisional Funding Algorithm |
|
|---|---|
| Stakeholder Input Deadline: | December 8, 2022 |
| Draft Report Posted: | January 26, 2023 |
| Stakeholder Feedback Deadline: | February 2, 2023 |
| Final Report Posted: | March 8, 2023 |
Files
Last Updated : March 8, 2023